Melanovytic tumor development in transgenic mice carrying the ret oncogene

携带ret癌基因的转基因小鼠黑素细胞肿瘤的发展

基本信息

  • 批准号:
    02670164
  • 负责人:
  • 金额:
    $ 1.54万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
  • 财政年份:
    1990
  • 资助国家:
    日本
  • 起止时间:
    1990 至 1991
  • 项目状态:
    已结题

项目摘要

We generated four transgenic mouse lines which showed severe melanosis of the whole body by introducing the ret oncogene fused to the mouse metallothionein-I promoter-enhancer (MT/ret). Melanocytic tumors frequently developed in three of the four lines. Mice of one line developed tumors in the dermis of the face and neck, the leg muscle, the mediastinum and the retroperitoneal cavity while mice of the other two lines developed them predominantly in the dermis of the face. Northern hybridization and in situ hybridization analyses showed that tumors cells and nontumorous melanin-producing cells expressed the transgene at high levels. To analyze the signal transduction pathway of the ret oncogene product, we established a cell line (Mel-ret) from a melanocytic tumor developed in a MT/ret transgenic mouse. Unlike primary melanocytic tumors which did not showed malignant features, the Mel-ret cells had the metastatic ability when they were transplanted into nude mice. We detected 100kd, 125kd and 135kd tyrosine phosphorylated proteins in both cell lysates of melanocytic tumors and Mel-ret cells. In addition, an 85kd tyrosine phosphorylated band was present specifically in the Mel-ret cells. The overall level of tyrosine phosphorylation in the Mel-ret cells was much higher than that in the primary tumors, suggesting that the increase of tyrosine phosphorylation may be responsible for malignant transformation. Immunofluorescence and cell fractionation studies showed that the ret protein and most of tyrosine phosphorylated proteins in the Mel-ret cells localized in the membrane fraction.
我们产生了四个转基因小鼠品系,表现出严重的全身黑变病,通过引入ret癌基因融合到小鼠金属硫蛋白-I启动子-增强子(MT/ret)。黑素细胞肿瘤经常在三个四行。一个系的小鼠在面部和颈部、腿部肌肉、纵隔和腹膜后腔的真皮中形成肿瘤,而另外两个系的小鼠主要在面部的真皮中形成肿瘤。北方杂交和原位杂交分析表明,肿瘤细胞和非肿瘤黑色素产生细胞表达高水平的转基因。为了分析ret癌基因产物的信号转导途径,我们从MT/ret转基因小鼠中产生的黑素细胞肿瘤建立了细胞系(Mel-ret)。与原发性黑素细胞瘤不具有恶性特征不同,Mel-ret细胞移植到裸鼠体内后具有转移能力。我们在黑素细胞瘤和Mel-ret细胞的细胞裂解物中检测到100 kd、125 kd和135 kd酪氨酸磷酸化蛋白。此外,在Mel-ret细胞中特异性地存在一条85 kd的酪氨酸磷酸化条带。Mel-ret细胞中酪氨酸磷酸化的总体水平远高于原发肿瘤,提示酪氨酸磷酸化的增加可能是恶性转化的原因。免疫荧光和细胞分级分离研究表明,ret蛋白和大多数酪氨酸磷酸化蛋白在Mel-ret细胞定位于膜组分。

项目成果

期刊论文数量(22)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Toyoharu Yokoi et al: "Characterization of cell fusion in XC cells induceel by Suncus murinus mammary tumor virus" Archives of Virology. 115. 267-276 (1990)
Toyoharu Yokoi 等人:“Suncus murinus 乳腺肿瘤病毒诱导的 XC 细胞中细胞融合的特征”病毒学档案。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Masahiko Taniguchi et al.: "The ret oncogene products are membrane-bound glycoproteins phosphorylated on tyrosine residues in vivo." Biochem. Biophys. Res. Commun.181. 416-422 (1991)
Masahiko Taniguchi 等人:“ret 癌基因产物是体内酪氨酸残基磷酸化的膜结合糖蛋白。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Masahiko Taniguchi et al.: "The ret qncogene protlucts are memlraneーbound glycoproteins phosphorylated on Tyrosine reeidues in vivo" Biochem.Biophys.Res.Commun. 181. 416-422 (1991)
Masahiko Taniguchi 等人:“ret qncogene protlucts 是在体内酪氨酸残基上磷酸化的膜结合糖蛋白”Biochem.Biophys.Res.Commun. 181. 416-422 (1991)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Masahide Takahashi et al.: "Proliferation and neoplastic transformation of pigment cells in metallothionein/ret transgenic mice." Pigment Cell Res.
Masahide Takahashi 等人:“金属硫蛋白/ret 转基因小鼠色素细胞的增殖和肿瘤转化。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Takashi Iwamot et al.: "Preferential clevelopment of preーB bymphoma with drastically daonregulated Nーmyc in the Eμーret transgenic mice" European Journal of Immunology. 21. 1809-1814 (1991)
Takashi Iwamot 等人:“Eμ-ret 转基因小鼠中具有显着 daon 调节的 N-myc 的前 B 淋巴瘤的优先 clevelopment”欧洲免疫学杂志 21. 1809-1814 (1991)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

TAKAHASHI Masahide其他文献

TAKAHASHI Masahide的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('TAKAHASHI Masahide', 18)}}的其他基金

Mechanism of chemoresistance by HDAC1-associating protein and development of molecular targeted therapy
HDAC1相关蛋白的化疗耐药机制及分子靶向治疗的进展
  • 批准号:
    24650618
  • 财政年份:
    2012
  • 资助金额:
    $ 1.54万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Molecular mechanisms of postnatal angiogenesis and neurogenesis
出生后血管生成和神经发生的分子机制
  • 批准号:
    23249020
  • 财政年份:
    2011
  • 资助金额:
    $ 1.54万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Enhanced photoresponse in organically-modified oxo alternating copolymers
有机改性的含氧交替共聚物增强光响应
  • 批准号:
    22360276
  • 财政年份:
    2010
  • 资助金额:
    $ 1.54万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Organic-inorganic hybrid films with photo and stimuli responsive micro structures
具有光和刺激响应微结构的有机-无机杂化薄膜
  • 批准号:
    22655071
  • 财政年份:
    2010
  • 资助金额:
    $ 1.54万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Physiological functions of the Akt substrate Girdin and its family proteins and their roles in pathogenesis
Akt 底物 Girdin 及其家族蛋白的生理功能及其在发病机制中的作用
  • 批准号:
    19209013
  • 财政年份:
    2007
  • 资助金额:
    $ 1.54万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Regulation of cell proliferation by receptor tyrosine kinase
受体酪氨酸激酶对细胞增殖的调节
  • 批准号:
    17014039
  • 财政年份:
    2005
  • 资助金额:
    $ 1.54万
  • 项目类别:
    Grant-in-Aid for Scientific Research on Priority Areas
In vivo role of the GDNF/RET signaling pathway in morphogenesis and pathogenesis
GDNF/RET 信号通路在形态发生和发病机制中的体内作用
  • 批准号:
    15209014
  • 财政年份:
    2003
  • 资助金额:
    $ 1.54万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Development of low-melting glasses containing organic molecules for photoinduced refractive index change
开发含有有机分子的低熔点玻璃以实现光致折射率变化
  • 批准号:
    12555249
  • 财政年份:
    2000
  • 资助金额:
    $ 1.54万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Molecular Medicine of Neurodegenerative Disease and Malignant Tumor
神经退行性疾病和恶性肿瘤的分子医学
  • 批准号:
    10CE2006
  • 财政年份:
    1998
  • 资助金额:
    $ 1.54万
  • 项目类别:
    Grant-in-Aid for COE Research
Analysis of molecular mechanisms of cancer metastasis using transgenic mice
利用转基因小鼠分析癌症转移的分子机制
  • 批准号:
    09470062
  • 财政年份:
    1997
  • 资助金额:
    $ 1.54万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)

相似海外基金

In vivo calcium imaging during appetitive learning in HIV Tat transgenic mice exposed to cannabis
暴露于大麻的 HIV Tat 转基因小鼠食欲学习过程中的体内钙成像
  • 批准号:
    10696442
  • 财政年份:
    2023
  • 资助金额:
    $ 1.54万
  • 项目类别:
Modelling mechanisms of progressive chronic kidney disease in APOL1 high-risk live-donors using BAC-Transgenic mice
使用 BAC 转基因小鼠模拟 APOL1 高危活体供体的进行性慢性肾病的机制
  • 批准号:
    10726804
  • 财政年份:
    2023
  • 资助金额:
    $ 1.54万
  • 项目类别:
Cholesterol-related genes in response to brain deafferentation in normal and transgenic mice
胆固醇相关基因对正常和转基因小鼠脑传入神经阻滞的反应
  • 批准号:
    RGPIN-2020-04702
  • 财政年份:
    2022
  • 资助金额:
    $ 1.54万
  • 项目类别:
    Discovery Grants Program - Individual
Elucidation of the pathophysiology of schizophrenia / autism spectrum disorder using EP400 gene transgenic mice
使用 EP400 基因转基因小鼠阐明精神分裂症/自闭症谱系障碍的病理生理学
  • 批准号:
    22K07582
  • 财政年份:
    2022
  • 资助金额:
    $ 1.54万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Investigating the acute cognitive outcomes of repetitive mild traumatic brain injury in transgenic mice
研究转基因小鼠重复性轻度创伤性脑损伤的急性认知结果
  • 批准号:
    486121
  • 财政年份:
    2022
  • 资助金额:
    $ 1.54万
  • 项目类别:
    Studentship Programs
Cholesterol-related genes in response to brain deafferentation in normal and transgenic mice
胆固醇相关基因对正常和转基因小鼠脑传入神经阻滞的反应
  • 批准号:
    RGPIN-2020-04702
  • 财政年份:
    2021
  • 资助金额:
    $ 1.54万
  • 项目类别:
    Discovery Grants Program - Individual
Development of transgenic mice to visualize mitochondrial stress for understanding the pathogenesis of age-related diseases
开发转基因小鼠来可视化线粒体应激,以了解与年龄相关的疾病的发病机制
  • 批准号:
    21K15377
  • 财政年份:
    2021
  • 资助金额:
    $ 1.54万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Development and preclinical testing in human cell models and transgenic mice of a novel treatment for Schinzel-Giedion Syndrome
辛泽尔-吉迪翁综合征新疗法的开发和在人类细胞模型和转基因小鼠中的临床前测试
  • 批准号:
    430820
  • 财政年份:
    2020
  • 资助金额:
    $ 1.54万
  • 项目类别:
    Operating Grants
Analysis of Psmb8 mutation-transgenic mice, model of Nakajo-Nishimura syndrome
Psmb8 突变转基因小鼠 Nakajo-Nishimura 综合征模型分析
  • 批准号:
    19K08780
  • 财政年份:
    2020
  • 资助金额:
    $ 1.54万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Cholesterol-related genes in response to brain deafferentation in normal and transgenic mice
胆固醇相关基因对正常和转基因小鼠脑传入神经阻滞的反应
  • 批准号:
    RGPIN-2020-04702
  • 财政年份:
    2020
  • 资助金额:
    $ 1.54万
  • 项目类别:
    Discovery Grants Program - Individual
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了